Answers are grounded in this paper and cite their sources.
Maternal uniparental disomy of chromosome 6 (UPD(6)mat) is an extremely rare condition associated with fetal growth restriction, but its phenotypic spectrum and pathogenesis remain incompletely understood. Through screening of cohorts comprising 309 individuals born small-for-gestational age and 835 patients presenting with Silver–Russell syndrome (SRS)-like features (1,144 in total), we identified four (0.35%) new Japanese patients with UPD(6)mat, who underwent detailed clinical and molecular characterization. Molecular analyses included pyrosequencing, MethylationEPIC array profiling, microsatellite marker analysis, chromosomal microarray analysis, short-read exome sequencing, and Nanopore long-read sequencing for phased, chromosome-wide methylation profiling of chromosome 6. All four patients had severe fetal growth restriction and fulfilled the Netchine–Harbison clinical scoring system criteria for SRS. All were delivered preterm, at 27–29 weeks of gestation, frequently with oligohydramnios and placental underdevelopment. All three male patients had urogenital anomalies, including cryptorchidism and/or hypospadias, and three patients exhibited dysglycemia. Methylation analyses demonstrated hypermethylation at known germline maternally methylated differentially methylated regions (DMRs) on chromosome 6, involving all four DMRs in three patients and three DMRs in one patient, with no evidence of multilocus imprinting disturbance. Microsatellite marker and chromosomal microarray analyses confirmed mixed maternal heterodisomy and isodisomy involving the entire chromosome 6 in three patients and segmental maternal UPD affecting 6q22.3–qter in one patient. Nanopore long-read sequencing confirmed these findings and identified no additional parent-of-origin–dependent methylation differences across chromosome 6. Short-read exome sequencing revealed no pathogenic homozygous variants explaining the shared core phenotype. UPD(6)mat represents a recognizable SRS-like condition characterized by severe pre- and postnatal growth restriction, frequent extreme prematurity, urogenital anomalies, and possible dysglycemia. Epigenetic disturbance appears largely confined to the known germline maternally methylated DMRs on chromosome 6, supporting a model in which imprinting dysregulation, potentially involving loss of paternal PLAGL1 expression, is compounded by placental insufficiency, while recessive allele unmasking may contribute to phenotypic variability.
No takes yet. Share an insight, caveat, or question.
Yamazawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: